Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte CoTSE:7792 +0.47%92 EV-to-EBIT is 5.62 as of Aug. 30, 2026, which is 14% below its 10-year median of 6.50. GuruFocus rates TSE:7792 with a GF Score™ of 92/100 and a GF Value™ of 円1,565.81 (Fairly Valued). The stock has 2 warning signs investors should review. Among 477 Medical Devices & Instruments companies, Colan Totte Co ranks better than 89.94% on this metric.
The historical rank and industry rank for Colan Totte Co's EV-to-EBIT or its related term are showing as below:
TSE:7792'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.42 Med: 6.5 Max: 86.82
Current: 5.62
During the past 7 years, the highest EV-to-EBIT of Colan Totte Co was 86.82. The lowest was 4.42. And the median was 6.50.
TSE:7792's EV-to-EBIT is ranked better than 89.94% of 477
companies
in the Medical Devices & Instruments industry
Industry Median: 18.99
vs TSE:7792: 5.62
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Colan Totte Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円10,292 Mil.
Colan Totte Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,072 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Colan Totte Co EV-to-EBIT Related Terms
Colan Totte Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Colan Totte Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Colan Totte Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Colan Totte Co's EV-to-EBIT falls into.
Colan Totte Co's current Enterprise Value is 円11,651 Mil.
Colan Totte Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,072 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Colan Totte Co (TSE:7792) has a EV-to-EBIT of 5.62 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Colan Totte Co and its competitors. This is 14% below median its historical median of 6.50. Over the past decade, Colan Totte Co's EV-to-EBIT has ranged from 4.42 to 86.82. According to the industry distribution chart, Colan Totte Co ranks #48 out of 477 companies in the Medical Devices & Instruments industry, placing it in the top 10.1%.
Is Colan Totte Co's EV-to-EBIT too high?
Colan Totte Co's current EV-to-EBIT of 5.62 is 14% below median its 10-year median of 6.50. Over the past 10 years, this metric has ranged from a low of 4.42 to a high of 86.82. The Medical Devices & Instruments industry median EV-to-EBIT is 18.99. Colan Totte Co's value of 5.62 is 70.4% below this industry median. Based on the distribution chart, Colan Totte Co ranks #48 out of 477 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Colan Totte Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Colan Totte Co ranks #48 out of 477 companies for EV-to-EBIT. This places Colan Totte Co in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.99. Colan Totte Co's value of 5.62 is 70.4% below this benchmark. Historically, Colan Totte Co's own EV-to-EBIT has ranged from 4.42 to 86.82 over the past decade. While the company's 10-year median is 6.50 vs. the industry median of 18.99, Colan Totte Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.99, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Colan Totte Co's current EV-to-EBIT of 5.62 is 70.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Colan Totte Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Colan Totte Co's current EV-to-EBIT is 5.62, which is 14% below median its own 10-year median of 6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,565.81, compared to a current price of 円1,492.00 — trading 4.7% below its estimated fair value. The current EV-to-EBIT is 5.62, which is 14% below median its 10-year median of 6.50 and 70.4% below the Medical Devices & Instruments industry median of 18.99. Colan Totte Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current EV-to-EBIT is 5.62 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,492.00 is trading 4.7% below its estimated GF Value™ of 円1,565.81.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
EV-to-EBIT: 5.62 (14% below median its 10-year median of 6.50)
GF Value™: 円1,565.81 vs. price of 円1,492.00 (4.7% below fair value)
Industry Position: 70.4% below the Medical Devices & Instruments median (#48 of 477)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
92GF Score
Get the complete analysis for TSE:7792
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
